← Eichor
Study identifier: NCT07216872 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)

Condition: Alcohol Use Disorder · Alcoholism · Alcohol Abuse  ·  Sponsor: Brainsway

PhaseNA
Planned participants186
Who can joinAll sexes, 18 Years to 86 Years
Healthy volunteersNo

About this study

The study will compare alcohol use in two groups of subjects. One group will be assigned to the Deep TMS treatment and the other group will be assigned to the sham treatment. This is a prospective, 6-month, double blind, randomized, controlled, multi-center trial in outpatients recruited in both academic and private research centers. The study population will consist of subjects diagnosed with moderate to severe AUD. The study is comprised of three phases: 1. Pre-study Screening and Baseline Phase 2. Acute Treatment Phase and 3. Maintenance Treatment and Follow up Phase Subjects of all ethnic and gender categories, ages ranging between 18-86 years will be screened for study eligibility according to the inclusion and exclusion criteria. Subjects who meet the eligibility criteria and are willing to sign an informed consent form will be enrolled in the study. The subjects' demographic and baseline characteristics, as well as their overall medical condition will be assessed prior to treatment administration. Eligible patients will be randomized with a 1:1 ratio to one of two study groups (treatment or sham) and stratified by site. Randomization will be employed to avoid bias in the assignment of subjects to treatment group. All subjects will undergo the same treatment regimen, regardless of the assigned treatment group. The acute treatment phase will include 15 treatment visits over a period of 3-5 weeks. The Maintenance Treatment \& Follow-up phase will include one treatment…

This description comes directly from the study's public registry record.

Talk to the study team

Ahava Stein  ·  +972-9-7670002  ·  ahava@asteinrac.com

Always discuss trial participation with your own doctor first.

Locations (9)

Alpha Neuron LLCTuscaloosa, Alabama, United StatesRecruiting
Kadima NeuropsychiatryLa Jolla, California, United StatesRecruiting
DTMS Center LLCWest Palm Beach, Florida, United StatesRecruiting
Rosecrance River NorthChicago, Illinois, United StatesRecruiting
ManuMind Interventional PsychiatryWoodbury, New York, United StatesRecruiting
Optimum Wellness and TMSColumbus, Ohio, United StatesRecruiting
Active Path Mental HealthPortland, Oregon, United StatesRecruiting
PsyCareSouth Charleston, West Virginia, United StatesRecruiting
Soroka Medical CenterBeersheba, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07216872